A medical trial found CBD reduced seizures in patients with a rare and severe form of epilepsy. Adjunctive cannabidiol, or Epidiolex, was used to treat patients with tuberous sclerosis complex (TSC), during a phase III pivotal trial, reports MedPage Today. Seizure frequency dropped from baseline by 49% with daily doses of CBD at 25mg per … Continue reading CBD breakthrough in severe epilepsy trial